Expression of the FGFR1 gene in human breast-carcinoma cells (Q28609135)

2

1 reference

3 February 2017

P. Parc

3

1 reference

3 February 2017

F. Penault-Llorca

4

1 reference

3 February 2017

J. Planche

5

1 reference

3 February 2017

O. deLapeyriere

6

1 reference

3 February 2017

D. Birnbaum

International Journal of Cancer

7

1 reference

3 February 2017

language of work or name

English

0 references

publication date

1 November 1994

1 reference

3 February 2017

1 reference

3 February 2017

59

1 reference

3 February 2017

3

1 reference

3 February 2017

373–378

1 reference

3 February 2017

Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910590314

p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910590314

Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910590314

Immunocytochemical identification of basic fibroblast growth factor in the developing rat mammary gland: variations in location are dependent on glandular structure and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910590314

Fibroblast stimulation of breast cancer cell growth in a serum-free system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910590314

Stromal influences on breast cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910590314

Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910590314